We are live on ! Find out more

1,619 hedge funds and large institutions have $126B invested in Merck in 2014 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 602 increasing their positions, 699 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 53

5% more funds holding in top 10

Funds holding in top 10: 140147 (+7)

0% more call options, than puts

Call options by funds: $950M | Put options by funds: $950M

0% less funds holding

Funds holding: 1,6211,619 (-2)

1% less capital invested

Capital invested by funds: $127B → $126B (-$978M)

1.04% less ownership

Funds ownership: 78.25%77.21% (-1%)

14% less repeat investments, than reductions

Existing positions increased: 602 | Existing positions reduced: 699

Holders
1,619
Holders Change
-2
Holders Change %
-0.12%
% of All Funds
46.95%
Holding in Top 10
147
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+5%
% of All Funds
4.26%
New
65
Increased
602
Reduced
699
Closed
53
Calls
$950M
Puts
$950M
Net Calls
+$352K
Net Calls Change
-$100M
Name Holding Trade Value Shares
Change
Change in
Stake
FA
1551
Friess Associates
Delaware
$145K
AW
1552
Alpha Windward
Massachusetts
$142K
BBPWM
1553
Blue Bell Private Wealth Management
Pennsylvania
$139K
ZTNA
1554
Zions Trust National Association
Utah
$137K -$11.7K -209 -8%
SA
1555
SRH Advisors
Kansas
$136K
PCM
1556
Prelude Capital Management
New York
$128K +$62.3K +1,109 +96%
NCM
1557
Nelson Capital Management
California
$123K -$20.1K -358 -14%
RIA
1558
Regal Investment Advisors
Michigan
$121K -$16.2K -288 -12%
TCM
1559
TD Capital Management
Tennessee
$120K +$842 +15 +0.7%
RCWMU
1560
Rothschild & Co Wealth Management (UK)
United Kingdom
$119K
SCA
1561
Strategic Capital Alternatives
United States
$116K +$115K +2,054 New
CAL
1562
Capital Advisors Ltd
Ohio
$114K
PCTC
1563
Perkins Coie Trust Company
Washington
$113K +$17.6K +314 +19%
GP
1564
GLG Partners
United Kingdom
$102K -$806K -14,356 -89%
RAM
1565
Riggs Asset Management
Pennsylvania
$92K +$91.3K +1,626 New
FNBSF
1566
First National Bank Sioux Falls
South Dakota
$87K
ACS
1567
Archford Capital Strategies
Illinois
$84K +$56 +1 +0.1%
LWM
1568
LBA Wealth Management
Florida
$83K +$4.55K +81 +6%
JG
1569
Jefferies Group
New York
$82K -$3.22M -57,325 -98%
FMB
1570
Field & Main Bank
Kentucky
$79K -$14.7K -262 -16%
DA
1571
Dunvegan Associates
California
$75K
VC
1572
Vestor Capital
Illinois
$70K +$69K +1,229 New
ST
1573
Somerset Trust
Pennsylvania
$65K
SEC
1574
Seven Eight Capital
New York
$64.1K -$383K -6,812 -86%
SAC
1575
Smith Affiliated Capital
New York
$54.8K

MRK Hedge Fund Activity: Q3 2014 in Review

1,619 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2014, worth a combined $126B — down 0.77% from $127B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new MRK positions and 53 closed out — a net gain of 12 holders — while 602 added to existing stakes and 699 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $434M. The largest seller was Norges Bank, cutting an estimated $1.3B.

  • 1,619 institutional investors held Merck (MRK) as of Q3 2014, down from 1,621 in Q2 2014.
  • Funds reported $126B of Merck stock for Q3 2014, down 0.77% quarter-over-quarter.
  • 65 funds opened new Merck positions in Q3 2014 and 53 closed out, a net change of +12 holders.
  • The largest Merck buyer in Q3 2014 was JP Morgan Chase, an estimated $434M added.
  • The largest Merck seller in Q3 2014 was Norges Bank, an estimated $1.3B sold.

Based on aggregated 13F filings for Q3 2014.